Clinical Operations and Growth of FSP White Paper

The evolution of clinical operations and the growth of FSP partnerships

Conducting clinical studies has always required a wide range of resources, but over the years the way those resources are deployed has evolved. Biopharmaceutical, biotech and medical device organizations now have a variety of options for clinical monitoring and site management, including functional service provider (FSP) and full-service outsourcing (FSO) models, or a hybrid solution combining the two.

This white paper examines how clinical operations have evolved to overcome study sponsors’ biggest challenges and ensure they continually advance new medicines and medical devices, and how the FSP model contributes to success.

In this white paper, you will learn more about:

• The drivers behind the evolution of staffing models
• The ascendancy of the FSP model for supporting on-time, on-budget trials
• The value of working with an FSP partner with a global reach
• The role of new technologies and how FSPs support their delivery
• The FSP’s role in ensuring patient diversity
• Clinical operations leaders as thought leaders